Skip to content

Cyclerion (United States)

Request correction

Corporate brand

Unclaimed

Cyclerion Therapeutics is a biopharmaceutical company that announced a merger agreement with Korsana Biosciences in April 2026.

Last updated September 16, 2026

AI crawler reads

No AI crawler has read this profile yet.

Overview

Cyclerion Therapeutics is a biopharmaceutical company. In April 2026, Cyclerion Therapeutics and Korsana Biosciences announced a merger agreement. In September 2026, Korsana Biosciences completed the closing of its merger with Cyclerion Therapeutics alongside a previously announced private placement of $380 million.

History

In April 2026, Cyclerion Therapeutics and Korsana Biosciences announced a merger agreement. In September 2026, Korsana Biosciences completed the closing of its merger with Cyclerion Therapeutics and a previously announced private placement of $380 million.

Sources2 sources

Cite this profile: Cite the canonical profile. /brand-wiki/cyclerion-united-states · Editorial policy · How profiles are compiled